Therefore, in addition to the increased level of serum IL-18 and IL-1β, the deregulated activation of these inflammasomes may exacerbate the cell death, contributing to the inflammatory process and its maintenance in RA disease. The gene discussed is IL1B; the disease is rheumatoid arthritis.